METHYLPREDNISOLONE ACETATE Manufacturer Supplier in PCD Pharma Franchise
![METHYLPREDNISOLONE ACETATE 80 mg/2ml](https://matinspharma.com/wp-content/uploads/2024/03/Matidrol-80-PhotoRoom.png-PhotoRoom-1030x768.png)
BRAND NAME FOR METHYLPREDNISOLONE ACETATE IN PCD PHARMA FRANCHISE – MATIDROL-80
COMPOSITION: METHYLPREDNISOLONE ACETATE 80 mg/2ml
For rates and Schemes – Contact 8284010553
Introduction of METHYLPREDNISOLONE ACETATE
Matidrol-80, meticulously formulated by Matins Pharma, delivers the therapeutic benefits of Methylprednisolone Acetate 80 mg/2ml, offering a potent solution for a range of inflammatory and immunologic conditions. Matins Pharma, a reputable supplier in PCD Pharma Franchise and Third-Party Manufacturing, adheres to stringent quality standards to ensure efficacy and safety in pharmaceutical products. Matidrol-80 stands as a reliable option for alleviating inflammation and managing various disorders, empowering patients to regain their health and well-being.
Uses of METHYLPREDNISOLONE ACETATE
Matidrol-80, containing Methylprednisolone Acetate 80 mg/2ml, serves a crucial role in the treatment of numerous medical conditions. Methylprednisolone is a potent corticosteroid with anti-inflammatory, immunosuppressive, and antiallergic properties. Matidrol-80 finds application in conditions such as allergic reactions, asthma, rheumatic disorders, dermatologic conditions, autoimmune diseases, and certain cancers. By suppressing the immune response and reducing inflammation, Matidrol-80 effectively mitigates symptoms and improves patients’ quality of life.
Side Effects of METHYLPREDNISOLONE ACETATE
While Matidrol-80 is generally well-tolerated, it’s essential to be aware of potential side effects that may occur. Common side effects of Methylprednisolone Acetate 80 mg/2ml may include fluid retention, increased appetite, weight gain, mood changes, insomnia, and gastrointestinal disturbances. Long-term use of corticosteroids like Methylprednisolone may lead to adverse effects such as osteoporosis, hypertension, diabetes, and increased susceptibility to infections. Patients should be monitored closely for signs of adverse reactions, and treatment should be tailored to minimize risks.
Safety Advice of METHYLPREDNISOLONE ACETATE
Ensuring patient safety is paramount when administering Matidrol-80. Healthcare professionals should exercise caution when prescribing Methylprednisolone to patients with pre-existing medical conditions such as diabetes, hypertension, or peptic ulcer disease. Dosage adjustments may be necessary in patients with impaired renal or hepatic function. Long-term use of Matidrol-80 should be accompanied by regular monitoring of vital signs, blood glucose levels, and bone density. Patients should be educated on the potential risks and benefits of treatment, and any concerns should be promptly addressed by healthcare providers.
Dosage of METHYLPREDNISOLONE ACETATE
The dosage of Matidrol-80 may vary depending on the specific condition being treated, the severity of symptoms, and the patient’s individual response to therapy. In general, the recommended dose for adults is one vial of Matidrol-80 (containing Methylprednisolone Acetate 80 mg/2ml) administered intramuscularly or intravenously. The frequency and duration of treatment will depend on the underlying condition and the patient’s clinical response. Dosage adjustments may be necessary in certain populations, such as elderly patients or those with compromised immune function.
The onset of action of Methylprednisolone Acetate 80 mg/2ml in Matidrol-80 varies depending on the condition being treated and the route of administration. Intravenous administration may result in a more rapid onset of action compared to intramuscular injection. Patients may experience symptomatic improvement within hours to days of initiating treatment with Matidrol-80. However, the full therapeutic effects may take several days to weeks to manifest fully, particularly in chronic conditions. It’s essential for patients to adhere to the prescribed treatment regimen and follow-up with healthcare providers for monitoring of symptoms and adjustments to therapy as needed.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF METHYLPREDNISOLONE ACETATE
Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality METHYLPREDNISOLONE ACETATE 80 mg/2ml under the brand name MATIDROL-80.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise: